Definition: Signaling proteins in the immune system.
Major Classes:
Interleukins (ILs): Regulate immune responses and inflammation.
Interferons (IFNS): Primarily involved in antiviral responses.
Tumor Necrosis Factor (TNF): Promotes inflammation and cell death.
Chemokines: Attract leukocytes to sites of infection or inflammation.
10. PAMPs vs. PRRs
PAMPS: Pathogen-associated molecular patterns.
PRRs: Pattern recognition receptors.
Types of PRRs:
TLRs (Toll-like receptors): Located on the cell surface or endosomes.
NLRS (NOD-like receptors): Located in the cytoplasm.
RLRS (RIG-I-like receptors): Located in the cytoplasm; recognize viral RNA.
11. ¡AVPs in Viral Response
¡AVPS: Inactive antiviral proteins.
Role: Activated by interferons; inhibit viral replication.
12. Complement Cascade Outcomes
Opsonization: Coating of pathogens to facilitate phagocytosis.
Inflammation: Release of complement components that attract and activate immune cells.
Membrane Attack Complex (MAC): Formation of pores in microbial membranes, leading to cell lysis.
13. Steps in Phagocytosis; Macrophages vs. Neutrophils
Steps:
Recognition and attachment.
Engulfment and formation of phagosome.
Formation of phagolysosome.
Digestion and degradation.
Exocytosis of debris.
Macrophages: Long-lived; reside in tissues; involved in antigen presentation.
Neutrophils: Short-lived; recruited to sites of infection; highly phagocytic.
14. Features of Inflammation
Signs: Redness, heat, swelling, pain.
Relation to Immune Response: Inflammation brings immune cells to sites of injury or infection; increases permeability and promotes healing.
CHAPTER 15: The Adaptive Immune Response
1. Main Characteristics of the Adaptive Immune Response
Timing: Delayed compared to innate immunity.
Benefits:
Specificity for individual antigens.
Memory response for stronger future responses.
Ability to distinguish between self and non-self.
2. Primary vs. Secondary Adaptive Immune Responses
Primary Response: First exposure to an antigen; typically slower and less robust.
Secondary Response: Subsequent exposure to the same antigen; faster and stronger due to memory cells.
3. Humoral vs. Cell-Mediated Responses
Humoral:
Cells: B cells.
Characteristics: Production of antibodies that target extracellular pathogens and toxins.
Cell-Mediated:
Cells: T cells.
Characteristics: Direct killing of infected cells; activation of macrophages and other immune cells.
4. Naïve, Activated, Effector, and Memory Lymphocytes
Naïve: Lymphocytes that have not yet encountered their specific antigen.
Activated: Lymphocytes that have encountered their antigen and are undergoing proliferation.
Effector: Lymphocytes that are actively involved in clearing pathogens.
Memory: Lymphocytes that retain information about specific antigens for faster future responses.
5. Lymphatic System and Its Components
Lymphatic Vessels: Transport lymph; contain valves to prevent backflow.
Primary Lymphoid Organs: Where lymphocytes develop; includes bone marrow (B cells) and thymus (T cells).
Secondary Lymphoid Organs: Where lymphocytes interact with antigens; includes lymph nodes, spleen, and mucosa-associated lymphoid tissue (MALT).
6. Antigen vs. Epitope
Antigen: Any substance that can elicit an immune response.
Epitope: Specific part of an antigen recognized by immune receptors.
Cells/ Receptors: B cells recognize antigens via B cell receptors (BCRs), while T cells recognize antigen fragments presented by MHC molecules via T cell receptors (TCRs).
7. B Cell vs. T Cell Receptors
BCRs:
Bind free antigens.
Can recognize proteins, carbohydrates, and lipids.
TCRs:
Bind antigen fragments presented by MHC molecules.
Recognize only proteins.
8. Steps in the Humoral Immune Response
Naïve B Cells: Recognize and bind antigens via BCR.
Activation: B cells require help from T cells (specifically, CD4+ helper T cells).
Differentiation: B cells differentiate into plasma cells (which produce antibodies) and memory B cells.
Antibodies: Target extracellular pathogens for clearance.
9. Regions of Antibodies; Mechanisms of Antibody Activity
T Cell Help: Requires interaction with CD4+ helper T cells for full activation.
Cytokine Signals: Further stimulate B cell proliferation and differentiation.
11. Helper Cells and Cytotoxic Cells
Helper T Cells:
Recognize antigens presented by MHC class II.
Typically recognize extracellular pathogens.
Effector functions: Help activate B cells, macrophages, and cytotoxic T cells.
Cytotoxic T Cells:
Recognize antigens presented by MHC class I.
Typically recognize intracellular pathogens.
Effector functions: Directly kill infected cells.
12. MHC and Its Role in Cell-Mediated Immunity
Definition: Major histocompatibility complex.
Role: Presents antigen fragments to T cells.
Types:
MHC Class I: Expressed on all nucleated cells; presents to cytotoxic T cells.
MHC Class II: Expressed on antigen-presenting cells (APCS); presents to helper T cells.
13. Antigen Presentation to T Cells by APCs
APCs: Includes dendritic cells, macrophages, and B cells.
Location: Occurs in secondary lymphoid organs (e.g., lymph nodes, spleen).
Molecules Involved:
MHC Class II: Presents to helper T cells.
MHC Class I: Presents to cytotoxic T cells.
14. Selection in Primary Lymphoid Organs
Positive Selection: Ensures T cells recognize self-MHC.
Negative Selection: Eliminates T cells that react strongly with self-antigens.
Purpose: To create a self-tolerant and functional T cell population.
15. Natural Killer Cells
Definition: A type of lymphocyte involved in innate immunity.
Mechanisms of Action:
Direct Killing: Induces apoptosis in virus-infected or cancerous cells.
Antibody-Dependent Cellular Cytotoxicity (ADCC): Targets antibody-bound cells for destruction.
CHAPTER 17: The Applications of the Immune Response
1. Immunization vs. Immunotherapy
Immunization: Process of inducing immunity against a specific disease.
Immunotherapy: Therapeutic use of immune system components to treat or prevent diseases.
2. Natural vs. Artificial Immunity; Active vs. Passive Immunity
Natural Immunity: Acquired through natural exposure to pathogens.
Artificial Immunity: Acquired through deliberate means (e.g., vaccination).
Active Immunity: Results from the activation of the immune system, leading to memory formation.
Passive Immunity: Provides temporary protection through transferred antibodies.
Examples:
Illness: Natural, active immunity.
Antiserum: Artificial, passive immunity.
Breastfeeding: Natural, passive immunity.
Vaccine: Artificial, active immunity.
3. Immunoglobulins and Their Types
Definition: Antibodies produced by B cells.
Types:
IgG: Most common; found in blood and extracellular fluid; crosses placenta.
IgM: First antibody produced; involved in primary immune response.
IgA: Found in mucosal sites (e.g., respiratory and gastrointestinal tracts).
IgE: Involved in allergic reactions and defense against parasites.
IgD: Present on naïve B cells; role in immune response not fully understood.
4. Definition and Benefits of Vaccines; Herd Immunity
Definition: Biological preparations that provide active acquired immunity to specific diseases.
Benefits: Protects the immunized individual and contributes to community-wide protection.
Herd Immunity: Occurs when a high percentage of a population is vaccinated, reducing the spread of disease and providing indirect protection to those who cannot be vaccinated.
5. Attenuated (Live) vs. Inactivated (Dead) Vaccines
Attenuated (Live):
Pros: Stronger and longer-lasting immune response; often requires fewer doses.
Cons: Risk of reversion to virulence; not suitable for immunocompromised individuals.
Inactivated (Dead):
Pros: Safer; no risk of reversion.
Cons: Weaker response; often requires multiple doses.
Types:
Killed Whole Cell: Whole pathogen killed.
Subunit: Contains parts of the pathogen.
Toxoid: Inactivated toxins.
Conjugate: Contains antigens linked to a carrier protein to enhance immunogenicity.
6. Importance of Vaccines in Society and Reasons for Vaccine Hesitancy
Importance: Vaccines are crucial for preventing diseases and maintaining public health.
Reasons for Vaccine Hesitancy:
Concerns about vaccine safety and side effects.
Misinformation and distrust in medical authorities.